亚太药业（002370）8月14日主力资金净流出2308.92万元

Group 1 - The core viewpoint of the news indicates that Asia-Pacific Pharmaceutical (002370) experienced a decline in stock price, closing at 6.8 yuan, down 2.16% as of August 14, 2025 [1] - The trading volume was 1,405,800 hands, with a transaction amount of 982 million yuan [1] - The net outflow of main funds was 23.09 million yuan, accounting for 2.35% of the transaction amount, with significant outflows from large orders [1] Group 2 - The latest financial performance of Asia-Pacific Pharmaceutical shows total operating revenue of 64.55 million yuan, a year-on-year decrease of 42.73% [1] - The net profit attributable to shareholders was 7.80 million yuan, down 160.25% year-on-year, while the non-recurring net profit was 7.56 million yuan, a decrease of 242.05% [1] - The company has a current ratio of 2.333, a quick ratio of 2.147, and a debt-to-asset ratio of 30.75% [1] Group 3 - Asia-Pacific Pharmaceutical, established in 2001 and located in Shaoxing, primarily engages in the pharmaceutical manufacturing industry [2] - The company has made investments in 7 enterprises and participated in 725 bidding projects [2] - It holds 120 trademark registrations and 78 patents, along with 135 administrative licenses [2]